News
The general manager of Bioiberica highlighted his companys commitment to a comprehensive approach to the treatment of osteoarthritis: prevention, chondroprotector drugs, and personalized medicine. Together, all these elements improve the patients quality of life.
The La mañana de la 1 program, broadcast by Televisión Española (TVE), devoted its saber vivir health section to the treatment of osteoarthritis.
The 19th edition of the symposium on glyccosaminoglyccans New developments of anticoagulant and non-anticoagulant glycosaminoglycans and of other coagulation inhibitors, is the most important meeting dealing with glycosaminoglycans. It will be held on 22-24 September 2011 at Villa Vigoni (Loveno, Lake Como)
Bioiberica has recently formed a German subsidiary, BIOIBERICA GmbH, headed up by Mr Axel Schmidt.
Bioiberica closed 2009 with a turnover of $152 million and significant growth compared to the previous year. These results indicate that the company is on the right track and heading for a promising future.